Auvelity preliminary 4Q and full year 2024 net product sales of $92.6 million and $291.4 million , respectively Sunosi preliminary 4Q and full year 2024 net product revenue of $25.7 million and $93.8 million , respectively NEW YORK , Jan. 13, 2025 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc.
